Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Perella Weinberg Partners (PWP)

Financial Services Capital Markets
17.70 $
+18.4% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Perella Weinberg Partners.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 4 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Basics

Market Cap
1.7$B
Shares Outstanding
73Mio.
Float
93.7%
Beta
1.6

Performance

Perf. 1M
-11.70%
Perf. 3M
-10.10%
Perf. 6M
-11.00%
YTD Performance (%)
-6.20%
52-Week-High Distance
-37.8%
Perf. 1Y
-12.11%
Perf. 3Y
111.20%
Perf. 5Y
35.81%

Valuation

P/E
70.6
Forward P/E
0.0
PEG
P/B
6.5
P/S
2.5
EV/EBITDA
29.0
Price/FCF
19.2

Profitability

Gross Margin
96.7%
EBIT Margin
Net Margin
2.9%
Return on Equity
13.3%
Return on Assets
4.4%

Balance Sheet & Safety

Equity Ratio
negative equity
Debt/Equity
-1.2
Altman Z″
3.15
weak
Piotroski
2 out of 9

Growth

Sales Growth Last Quarter
-29.70%
EPS Growth Last Quarter
-92.40%
Sales Growth (Year)
-14.48%
Forward Sales Growth
24.31%
Forward EPS Growth
49.00%

Dividend

Dividend Yield
1.70%
Dividend Per Share (TTM)
0.28$
Payout Ratio
63.6%
Years Without a Cut
4Years
Increase Streak
0Years

Quality & Screener

Stage
4
RS Rating
21
EPS Rating
3
weak
Piotroski
2 out of 9
Fundamental Rating
D (41 out of 100)
Altman Z″
3.15

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 17.70 $
Price Target (average) 22.88 $

The price target sits 29.3% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

7. Aug 2026

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Sales Per Quarter ($M)
2024: Q4 · 225.7 $M Q4 2025: Q1 · 211.8 $M Q1 2025: Q2 · 155.3 $M Q2 2025: Q3 · 164.6 $M Q3 2025: Q4 · 219.2 $M Q4 2026: Q1 · 148.9 $M Q1 2026: Q2 · 156.5 $M Q2
Earnings Per Share Per Quarter ($)
2024: Q4 · 0.28 $ Q4 2025: Q1 · 0.23 $ Q1 2025: Q2 · 0.03 $ Q2 2025: Q3 · 0.06 $ Q3 2025: Q4 · 0.14 $ Q4 2026: Q1 · 0.01 $ Q1 2026: Q2 · 0.06 $ Q2
Net Margin Per Quarter (%)
2024: Q4 · 9.2 % Q4 2025: Q1 · 8.2 % Q1 2025: Q2 · 1.8 % Q2 2025: Q3 · 3.6 % Q3 2025: Q4 · 4.3 % Q4 2026: Q1 · 1.0 % Q1 2026: Q2 · 3.4 % Q2
Operating Cash Flow Per Quarter ($M)
2024: Q4 · 139.4 $M Q4 2025: Q1 · -176.5 $M Q1 2025: Q2 · 56.1 $M Q2 2025: Q3 · 59.2 $M Q3 2025: Q4 · 96.0 $M Q4 2026: Q1 · -109.7 $M Q1 2026: Q2 · 48.8 $M Q2
Free Cash Flow Per Quarter ($M)
2024: Q4 · 138.8 $M Q4 2025: Q1 · -177.6 $M Q1 2025: Q2 · 55.3 $M Q2 2025: Q3 · 57.6 $M Q3 2025: Q4 · 95.1 $M Q4 2026: Q1 · -111.8 $M Q1 2026: Q2 · 47.1 $M Q2
Sales Growth vs. Year-Ago Quarter (%)
2024: Q4 · 6.1 % Q4 2025: Q1 · 107.4 % Q1 2025: Q2 · -42.9 % Q2 2025: Q3 · -40.8 % Q3 2025: Q4 · -2.9 % Q4 2026: Q1 · -29.7 % Q1 2026: Q2 · 0.8 % Q2
EPS Growth vs. Year-Ago Quarter (%)
2025: Q3 · -74.5 % Q3 2025: Q4 · -51.0 % Q4 2026: Q1 · -93.6 % Q1 2026: Q2 · 100.0 % Q2
Price Change in Quarter (%)
2024: Q4 · 23.8 % Q4 2025: Q1 · -22.6 % Q1 2025: Q2 · 5.9 % Q2 2025: Q3 · 10.1 % Q3 2025: Q4 · -18.6 % Q4 2026: Q1 · 5.3 % Q1

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 0.28 226 6.10 9.20 139 139
2025: Q1 0.23 212 107.40 8.20 -177 -178
2025: Q2 0.03 155 -42.90 1.80 56 55
2025: Q3 0.06 -74.50 165 -40.80 3.60 59 58
2025: Q4 0.14 -51.00 219 -2.90 4.30 96 95
2026: Q1 0.01 -93.60 149 -29.70 1.00 -110 -112
2026: Q2 0.06 100.00 157 0.80 3.40 49 47
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Perella Weinberg Partners, eine unabhängige Beratungsfirma, bietet strategische und finanzielle Beratungsdienstleistungen in den USA, Großbritannien und international an. Es bietet Beratungsdienstleistungen zu strategischen und finanziellen Entscheidungen, zur Durchführung von Fusionen und Übernahmen, zum Aktionärsengagement…

Employees700
HeadquartersNew York, NY
Websitepwpartners.com
IPO Date20. Nov 2020

Management

Management
Name Title Birth Year
Peter Amory Weinberg A.C.A. Co-Founder, Founding Partner & Chairman 1958
Andrew Bednar J.D. CEO, Partner of New York & Director
Dietrich Becker Partner of London, President & Director 1963
Taylor Reinhardt Executive Director & Head of Investor Relations
Titus W. Leung J.D. Partner for Advisory Business - New York
Michael Grace Partner of Advisory - New York
Daniel Avrutsky Partner 1973
Michele Abrams Managing Director
Christopher Blake Partner of Healthcare Group
Saahil Sajnani Managing Director of New York

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?